Filing Flows › Edwards Lifesciences (EW) › Q2 2026
Edwards Lifesciences (EW) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 4, 2026
Edwards Lifesciences (EW) reported revenue of $1.7B for the second quarter 2026 (Q2 2026), +14% from a year earlier and +6% from the quarter before. Operating margin was 29.5%, net earnings $242M (13.9% of revenue).
Edwards Lifesciences, Q2 2026: revenue $1.7B (+14% year over year), operating margin 29.5%, net earnings $242M, operating cash flow $652M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7B | +6% | +14% |
| Gross profit | $1.3B | +5% | +14% |
| Operating profit | $513M | +7% | +25% |
| Net earnings | $242M | -36% | -27% |
| Operating cash flow | $652M | 15× | +125% |
| Free cash flow | $585M | — | +143% |
What changed
Revenue was $1.7B in Q2 2026, up 14% year over year and up 6% from the previous quarter. Transcatheter Aortic Valve Replacement was the largest line at 72% of revenue. Transcatheter Aortic Valve Replacement added $0.13B year over year (up 11%), 61% of the total change.
Gross margin was 77.5%, down 0.1 points from Q2 2025. Operating profit was $0.51B, a 29.5% margin (up 2.6 points year over year). Of the extra revenue versus Q2 2025, 49% reached operating profit, above the 27% margin then. Operating expenses grew 8% against revenue growth of 14%. Net earnings were $0.24B, down 27% year over year. The effective tax rate was 53.6%.
Operating cash flow was $0.65B (up 125% year over year), 270% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items added $0.33B. Capital expenditures of $0.07B left free cash flow of $0.58B.
Questions
What was Edwards Lifesciences' revenue in the second quarter 2026?
Edwards Lifesciences (EW) reported revenue of $1.7B for the second quarter 2026 (Q2 2026), +14% from a year earlier and +6% from the quarter before.
Was Edwards Lifesciences profitable in the second quarter 2026?
Operating profit was $513M (29.5% of revenue) and net earnings $242M.